Effectiveness of the Internet Attachment-Based Compassion Therapy (iABCT) to Improve the Quality of Life and Well-being in a Population With Chronic Medical Illness.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Medical Illness
- Sponsor
- University of Valencia
- Enrollment
- 68
- Locations
- 1
- Primary Endpoint
- Changes in quality of life
- Last Updated
- 4 years ago
Overview
Brief Summary
Compassion-Based Interventions are increasingly relevant as a potentially beneficial way to support people with chronic medical conditions and improve different outcomes related with the management of the disease. Online interventions The purpose of this study is to evaluate the effectiveness of the internet version of the attachment-based compassion therapy for improving quality of life in a population with chronic medical illness.
Detailed Description
Our participants will be randomized to one of the following two conditions: 1) the Internet version of the attachment-based compassion therapy, and 2) Waiting list (WL) control group. The corresponding evaluations of the outcomes will be carried out at different moments of the process: baseline, and a three- and six-month follow-up. This study will use the internet version of attachment-based compassion therapy (iABCT) for improving the quality of life in a population with chronic medical illness.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \> 18 years;
- •ability to understand and read Spanish;
- •access to a computer with the Internet; and
- •fulfill criteria for diagnosis of one of the following chronic medical conditions: diabetes, inflammatory bowel disease, fibromyalgia, low-back chronic pain, migraines, and other conditions.
Exclusion Criteria
- •Terminal disease;
- •severe psychiatric disorders comorbidities (schizophrenia, substance dependence, bipolar disorder, psychotic illness) or severe neurologic or medical condition; and
- •receiving psychological treatment or mindfulness training at the time of recruitment.
Outcomes
Primary Outcomes
Changes in quality of life
Time Frame: Baseline (week 0), 3-month follow-up, 6-month follow-up
EuroQol (EQ-5D; Badia et al., 1999). It is a self-report measures composed by five dimensions of functionality in daily-life and three levels of severity (1-3). A higher score in this scale indicates higher severity on the different areas of functioning in daily life.
Changes in wellbeing
Time Frame: Baseline (week 0), 3-month follow-up, 6-month follow-up
Pemberton Happiness Index (PHI; Hervás and Vázquez, 2013). The scale includes eleven items related to different domains of remembered well-being (general, hedonic, eudaimonic, and social well-being) and ten items related to experienced well-being (i.e., positive and negative emotional events that possibly happened the day before); the sum of these items produces a combined well-being index that range from 0 to 10. Higher levels indicate higher levels of wellbeing.
Secondary Outcomes
- Self-care and healthy behaviors(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Self-criticism(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Semi-structured qualitative interview(3-month follow-up (only intervention group), 6-month follow-up (only WL control group))
- Compassion and self-compassion(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Specific illness interference(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Symptomatology(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Social support(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Client's satisfaction(3-month follow up (only intervention group), 6-month follow-up (only WL control group))
- Attachmetn styles(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Illness perception(Baseline (week 0), 3-month follow-up, 6-month follow-up)
- Difficulties of the compassion practice(3-month follow-up (only intervention group), 6-month follow-up (only WL control group))
- Usability and client acceptance(3-month follow-up (only intervention group), 6-month follow-up (only WL control group))